Sugammadex and Cognitive Function
NCT02419352
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
160
Enrollment
OTHER
Sponsor class
Conditions
Post Operative Cognitive Dysfunction
Interventions
DRUG:
Sugammadex
DRUG:
Neostigmine/atropine
Sponsor
Attikon Hospital